MedPath

Sodium bicarbonate

Generic Name
Sodium bicarbonate
Brand Names
Alka-seltzer, Alka-seltzer Fruit Chews, Alka-seltzer Heartburn Relief, Bi-peglyte, Bibag, Bicart, Bss Ophthalmic Solution, Ceo-two, Colyte, Gavilyte-C, Gavilyte-G, Gavilyte-H and Bisacodyl, Gavilyte-N, Golytely, H.E.L.P.bicel, Hema Bp-38, Hemacart, Konvomep, Nulytely, Peglyte, Phoxillum, Physioneal 40, Prismasol, Zegerid, Zegerid Reformulated Aug 2006, Zegerid With Magnesium Hydroxide
Drug Type
Small Molecule
Chemical Formula
CHNaO3
CAS Number
144-55-8
Unique Ingredient Identifier
8MDF5V39QO

Overview

Sodium bicarbonate is a white, crystalline powder that is commonly used as a pH buffering agent, an electrolyte replenisher, systemic alkalizer and in topical cleansing solutions.

Background

Sodium bicarbonate is a white, crystalline powder that is commonly used as a pH buffering agent, an electrolyte replenisher, systemic alkalizer and in topical cleansing solutions.

Indication

Sodium bicarbonate is used for the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. Also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. Further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturateprotein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of blood pigments.

Associated Conditions

  • Barbiturate intoxication
  • Breast Cancer
  • Constipation
  • Dental Decay
  • Duodenal Ulcer
  • Dyspepsia
  • Gastro-esophageal Reflux Disease (GERD)
  • Gingival Bleeding
  • Heartburn
  • Helicobacter Infections
  • Hyperkalemia
  • Ischaemia
  • Metabolic Acidosis
  • Myocardial Infarction
  • Plaque, Dental
  • Pruritis of the skin
  • Skin Irritation
  • Upper GI Bleeding
  • Upset stomach
  • Zollinger-Ellison Syndrome
  • Abdominal bloating
  • Benign, active Gastric Ulcer
  • Methyl alcohol poisoning
  • Prophylaxis of Contrast-induced nephropathy
  • Salicylate poisoning
  • Severe Diarrhea
  • Swelling of the gums

FDA Approved Products

PEDIATRIC 8.4% SODIUM BICARBONATE
Manufacturer:HF Acquisition Co LLC, DBA HealthFirst
Route:INTRAMUSCULAR
Strength:84 mg in 1 mL
Approved: 2020/02/23
NDC:51662-1472
7.5% SODIUM BICARBONATE
Manufacturer:HF Acquisition Co LLC, DBA HealthFirst
Route:INTRAVENOUS
Strength:75 mg in 1 mL
Approved: 2020/02/23
NDC:51662-1463
PEG-3350 and Electrolytes
Manufacturer:Affordable Pharmaceuticals, LLC
Route:ORAL
Strength:6.74 g in 4 L
Approved: 2022/09/28
NDC:10572-101
Sodium Bicarbonate
Manufacturer:Fresenius Kabi USA, LLC
Route:INTRAVENOUS
Strength:42 mg in 1 mL
Approved: 2019/12/31
NDC:63323-083
SODIUM BICARBONATE
Manufacturer:Nivagen Pharmaceuticals, Inc.
Route:INTRAVENOUS
Strength:84 mg in 1 mL
Approved: 2024/03/08
NDC:75834-286

Singapore Approved Products

SODIUM BICARBONATE INTRAVENOUS INFUSION BP 4.2% w/v
Manufacturer:B BRAUN MELSUNGEN AG
Form:INJECTION
Strength:4.2% w/v
Online:Yes
Approved: 1998/06/26
Approval:SIN09851P
SODIUM BICARBONATE INJECTION BP 8.4%
Manufacturer:B BRAUN MELSUNGEN AG
Form:INJECTION
Strength:8.4 g/100 ml
Online:Yes
Approved: 1991/05/23
Approval:SIN05953P
SODIUM BICARBONATE INTRAVENOUS INFUSION 8.4% w/v
Manufacturer:B BRAUN MELSUNGEN AG
Form:INJECTION
Strength:8.4% w/v
Online:Yes
Approved: 1997/02/20
Approval:SIN09226P
GAVISCON DOUBLE ACTION LIQUID, SUSPENSION
Manufacturer:RECKITT BENCKISER HEALTHCARE (UK) LIMITED
Form:SUSPENSION
Strength:213MG/10ML
Online:Yes
Approved: 2011/09/19
Approval:SIN14016P
DUOSOL WITHOUT POTASSIUM SOLUTION FOR HAEMOFILTRATION
Manufacturer:B. Braun Avitum AG
Form:SOLUTION, STERILE
Strength:3.59g/1000ml
Online:Yes
Approved: 2019/08/20
Approval:SIN15783P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath